Gastroprotective effects of telmisartan on experimentally-induced gastric ulcers in rats

Pharmazie

Volumn 64, Issue 9, 2009, Pages 590-594

  Morsy, Mohamed A ^a   Ashour, O ^a   Amin, E ^a   Rofaeil, R ^a  

^a Minia University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; INDOMETACIN; MALONALDEHYDE; MUCIN; NITRATE; NITRIC OXIDE; NITRITE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN E2; RANITIDINE; TELMISARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD STRESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG PROTEIN BINDING; IMMOBILIZATION STRESS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STOMACH JUICE; STOMACH MUCOSA; STOMACH PH; STOMACH PROTECTION; STOMACH ULCER;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; BENZIMIDAZOLES; BENZOATES; COLD TEMPERATURE; DINOPROSTONE; GASTRIC JUICE; GASTRIC MUCOSA; INDOMETHACIN; MALE; MALONDIALDEHYDE; NITRIC OXIDE; RANITIDINE; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; STOMACH ULCER; STRESS, PSYCHOLOGICAL; TETRAZOLES;

EID: 75749154091     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.9581     Document Type: Article

References (31)

1. Beltrán AE, Briones AM, García-Redondo AB, Rodríguez C, Miguel M, Alvarez Y, Alonso MJ, Martínez-González, J, Salaices M (2009) p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats. J Hypertens 27: 142-154.
2. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43: 993-1002.
3. Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM (2003) Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 285: G414-423.
4. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52: 302-310.
5. Cipollone F, Fazia ML, Mezzetti A (2006) Role of angiotensin II receptor blockers in atherosclerotic plaque stability. Expert Opin Pharmacother 7: 277-285.
6. Ender F, Labancz T, Rosivall L (1993) Protective effects of the inhibition of the renin-angiotensin system against gastric mucosal lesions induced by cold-restraint in the rat. Acta Physiol Hung 81: 13-18.
7. Feldman M (1998) Gastric secretion. normal and abnormal. In: Feldman M, Scharschmidt BF, Sleisenger MH (Eds.) Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, 6th ed., Philadelphia, p. 587-603.
8. Hara N, Hara Y, Natsume Y, Goto Y (1991) Gastric hyperacidity and mucosal damage caused by hypothermia correlate with increase in GABA concentrations of the rat brain. Eur J Pharmacol 194: 77-81.
9. Heinemann A, Sattler V, Jocic M, Wienen W, Holzer P (1999) Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on rat gastric mucosal blood flow. Aliment Pharmacol Ther 13: 347-355.
10. Iqbal M, Dubey K, Anwer T, Ashish A, Pillai KK (2008) Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats. Pharmacol Rep 60: 382-390.
11. Kato S, Kitamura M, Korolkiewicz RP, Takeuchi K (1998) Role of nitric oxide in regulation of gastric acid secretion in rats: effects of NO donors and NO synthase inhibitor. Br J Pharmacol 123: 839-846.
12. Khattab MM, Gad MZ, Abdallah D (2001) Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion. Pharmacol Res 43: 463-467.
13. Marshall TG, Lee RE, Marshall FE (2006) Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Theor Biol Med Model 3: 1.
14. Martin GR, Wallace JL (2006) Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp Biol Med (Maywood) 231: 130-137.
15. Martín MJ, Jiménez MD, Motilva V (2001) New issues about nitric oxide and its effects on the gastrointestinal tract. Curr Pharm Des 7: 881-908.
16. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D (2005) Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57: 217-252.
17. Moore EW (1968) Determination of pH by the glass electrode: pH meter calibration for gastric analysis. Gastroenterology 54: 501-507.
18. Nakagiri A, Sunamoto M, Murakami M (2007) Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats. Inflammopharmacology 15: 171-174.
19. Overmier JB, Murison R (2000) Anxiety and helplessness in the face of stress predisposes, precipitates, and sustains gastric ulceration. Behav Brain Res 110: 161-174.
20. Sanyal AR, Denath OK, Bhattacharya SK, Gode KD (1971) The effect of cyproheptadine on gastric acidity. In: Pfeiffer CJ (Ed.) Peptic ulcer, Copenhagen, p. 312-318.
21. Sastry KV, Moudgal RP, Mohan J, Tyagi JS, Rao GS (2002) Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 306: 79-82.
22. Scalera F, Martens-Lobenhoffer J, Bukowska A, Lendeckel U, Täger M, Bode-Böger SM (2008) Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging. Hypertension 51: 696-703.
23. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C (2006) Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 101: 701-710.
24. Senay EC, Levine RJ (1967) Synergism between cold and restraint for rapid production of stress ulcers in rats. Proc Soc Exp Biol Med 124: 1221-1223.
25. Sonnenberg A (1988) Concordant occurrence of gastric and hypertensive diseases. Gastroenterology 95: 42-48.
26. Takano H, Komuro I (2009) Peroxisome proliferator-activated receptor gamma and cardiovascular diseases. Circ J 73: 214-220.
27. Takaya T, Kawashima S, Shinohara M, Yamashita T, Toh R, Sasaki N, Inoue N, Hirata K, Yokoyama M (2006) Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. Atherosclerosis 186: 402-410.
28. Till M, Gáti T, Rábai K, Szombath D, Székely JI (1988) Effect of [D-Met2, Pro5]enkephalinamide on gastric ulceration and transmucosal potential difference. Eur J Pharmacol 150: 325-330.
29. Unger T, Stoppelhaar M (2007) Rationale for double renin-angiotensin- aldosterone system blockade. Am J Cardiol 100: 25J-31J.
30. Welch WJ (2008) Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction. Hypertension 52: 51-56.
31. Winzler RJ (1955) Determination of serum glycoproteins. Methods Biochem Anal 2: 279-311.